Page last updated: 2024-10-30

mesalamine and Churg-Strauss Syndrome

mesalamine has been researched along with Churg-Strauss Syndrome in 1 studies

Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.

Churg-Strauss Syndrome: Widespread necrotizing angiitis with granulomas. Pulmonary involvement is frequent. Asthma or other respiratory infection may precede evidence of vasculitis. Eosinophilia and lung involvement differentiate this disease from POLYARTERITIS NODOSA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Morice, AH1
Kumwenda, J1
Qureshi, N1
Curran, A1

Other Studies

1 other study available for mesalamine and Churg-Strauss Syndrome

ArticleYear
Mesalazine activation of eosinophil.
    Lancet (London, England), 1997, Oct-11, Volume: 350, Issue:9084

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Churg-Strauss Syndrome; Colitis, Ulcerative; Eosinop

1997